1. Pink Sheet
  2. >>Market Access

Drugs' Net Price Only Growing Modestly, Express Scripts Finds

 
• By Cathy Kelly

Overall unit cost in commercial insurance market was up only 2.5% in 2016 despite 11% list increase for brands, PBM's Drug Trend Report concludes; findings could be counterpoint to public and policymaker concerns with drug pricing.

Express Scripts HQ

Unit costs for all prescription drugs rose only 2.5% for Express Scripts Holding Co.’s commercial insurance clients in 2016 despite a nearly 11% average increase in list pricing for brands, according to the pharmacy benefit manager’s most recent Drug Trend Report, released Feb. 6.

“Average list prices for brand drugs rose 10.7% in 2016. However, unit prices for medications purchased by our clients rose just 2.5%, 22% less than the rate of increase seen...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Pricing Debate

More from Market Access

Spain Slashes Wait Between EU Drug Authorization And Financing Decisions

 
• By Francesca Bruce

Spanish authorities say that that timelines for drug reimbursement decisions can be improved further with the right submissions from companies.

Spain Beats England To Tevimbra Reimbursement Recommendations

 
• By Francesca Bruce

Spanish authorities have published more pricing and reimbursement reports as part of a new drive to increase transparency.

‘Tectonic’ Arkansas PBM Legislation May Upend Industry

 
• By Tim Casey

Industry will fight hard to prevent other states or the federal government from adopting measures similar to Arkansas' law preventing PBMs from owning pharmacies.